Nephrocare Health IPO is much discussed among investors. This is a Book Build Issue of ₹871.05 crore which includes Fresh Issue of ₹353.40 crore and Offer For Sale (OFS) of ₹517.64 crore. Bidding for IPO started on 10 December 2025 and will close on 12 December 2025. Allotment is expected on 15 December 2025 and this share will be listed on BSE and NSE on 17 December 2025. The price band of this IPO has been fixed at ₹438 to ₹460 per share. For Retail Investors, one lot will contain 32 shares, for which the minimum investment amount will be ₹ 14,720 (at the upper price brand). Whereas for SMNI, a bid of 14 Lot (₹ 2,06,080) will have to be made and for bNII, 68 Lot (₹ 10,00,960) will have to be bid. There is also a special reservation for employees in this issue—83,532 shares, which will be given at a discount of ₹41. The Book Running Lead Manager of this IPO is ICICI Securities and Kfin Technologies is playing the role of Registrar. Nephrocare Health is a leading company providing Kidney Care and Diagnostic Services in India. Be sure to consult your financial advisor before investing in IPO. For more information see Nephrocare Health IPO RHP.
